Last reviewed · How we verify
Flucelvax seasonal vaccine
Flucelvax seasonal vaccine is a Biologic drug developed by University of Minnesota. It is currently in Phase 1 development.
At a glance
| Generic name | Flucelvax seasonal vaccine |
|---|---|
| Sponsor | University of Minnesota |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Pain
- Irritability
- Decreased appetite
- Nasopharyngitis
- COVID-19
- Somnolence
- Upper respiratory tract infection
- Erythema
- Influenza like illness
- Headache
- Pyrexia
- Fatigue
Key clinical trials
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (PHASE2)
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults (PHASE1)
- Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants (PHASE3)
- Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
- A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults (PHASE1)
- H1ssF Flu Vaccine Clinical Trial (PHASE1)
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine (PHASE1, PHASE2)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flucelvax seasonal vaccine CI brief — competitive landscape report
- Flucelvax seasonal vaccine updates RSS · CI watch RSS
- University of Minnesota portfolio CI
Frequently asked questions about Flucelvax seasonal vaccine
What is Flucelvax seasonal vaccine?
Flucelvax seasonal vaccine is a Biologic drug developed by University of Minnesota.
Who makes Flucelvax seasonal vaccine?
Flucelvax seasonal vaccine is developed by University of Minnesota (see full University of Minnesota pipeline at /company/university-of-minnesota).
What development phase is Flucelvax seasonal vaccine in?
Flucelvax seasonal vaccine is in Phase 1.
What are the side effects of Flucelvax seasonal vaccine?
Common side effects of Flucelvax seasonal vaccine include Pain, Irritability, Decreased appetite, Nasopharyngitis, COVID-19, Somnolence.
Related
- Manufacturer: University of Minnesota — full pipeline
- Compare: Flucelvax seasonal vaccine vs similar drugs
- Pricing: Flucelvax seasonal vaccine cost, discount & access